Crucell N.V. · Leiden The Netherlands
| Archimedesweg 4-6 | Phone: +31-71-519-91-01 |
| Leiden | Fax: +31-71-519-98-00 |
| 2333 CN | |
| The Netherlands | 
Map This Company |
Crucell N.V. Rankings
Company Description
Crucell wants to play a crucial role in the fight against deadly diseases. The global biotech firm develops, produces, and markets vaccines and antibodies to prevent and treat infectious diseases. Many of its products are based on its PER.C6 technology platform, and its primary product lines are focused on pediatric, travel, endemic (native to certain regions), and respiratory ailments. Crucell's marketed vaccines fight about a dozen major infectious diseases (including diptheria, hepatitis A and B, influenza, and typhoid) and are offered in more than 100 countries worldwide. The company was acquired by
Crucell N.V. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 1,300 |
Executives
18 executives listed for Crucell N.V.'s Leiden, The Netherlands location.
| Chairman | Jan Oosterveld | |
|---|---|---|
| President and CEO | Ronald Brus | |
| COO | Cees de Jong |